Overdose prevention and naloxone prescription for opioid users in San Francisco
- PMID: 20967505
- PMCID: PMC3005091
- DOI: 10.1007/s11524-010-9495-8
Overdose prevention and naloxone prescription for opioid users in San Francisco
Abstract
Opiate overdose is a significant cause of mortality among injection drug users (IDUs) in the United States (US). Opiate overdose can be reversed by administering naloxone, an opiate antagonist. Among IDUs, prevalence of witnessing overdose events is high, and the provision of take-home naloxone to IDUs can be an important intervention to reduce the number of overdose fatalities. The Drug Overdose Prevention and Education (DOPE) Project was the first naloxone prescription program (NPP) established in partnership with a county health department (San Francisco Department of Public Health), and is one of the longest running NPPs in the USA. From September 2003 to December 2009, 1,942 individuals were trained and prescribed naloxone through the DOPE Project, of whom 24% returned to receive a naloxone refill, and 11% reported using naloxone during an overdose event. Of 399 overdose events where naloxone was used, participants reported that 89% were reversed. In addition, 83% of participants who reported overdose reversal attributed the reversal to their administration of naloxone, and fewer than 1% reported serious adverse effects. Findings from the DOPE Project add to a growing body of research that suggests that IDUs at high risk of witnessing overdose events are willing to be trained on overdose response strategies and use take-home naloxone during overdose events to prevent deaths.
Figures
Similar articles
-
Attitudes about prescribing take-home naloxone to injection drug users for the management of heroin overdose: a survey of street-recruited injectors in the San Francisco Bay Area.J Urban Health. 2003 Jun;80(2):291-301. doi: 10.1093/jurban/jtg032. J Urban Health. 2003. PMID: 12791805 Free PMC article.
-
Brief overdose education is sufficient for naloxone distribution to opioid users.Drug Alcohol Depend. 2015 Mar 1;148:209-12. doi: 10.1016/j.drugalcdep.2014.12.009. Epub 2014 Dec 19. Drug Alcohol Depend. 2015. PMID: 25595053
-
Development and implementation of an opioid overdose prevention and response program in Toronto, Ontario.Can J Public Health. 2013 Apr 18;104(3):e200-4. doi: 10.17269/cjph.104.3788. Can J Public Health. 2013. PMID: 23823882 Free PMC article.
-
Twenty years of take-home naloxone for the prevention of overdose deaths from heroin and other opioids-Conception and maturation.Drug Alcohol Depend. 2017 Sep 1;178:176-187. doi: 10.1016/j.drugalcdep.2017.05.001. Epub 2017 May 25. Drug Alcohol Depend. 2017. PMID: 28654870 Review.
-
Are take-home naloxone programmes effective? Systematic review utilizing application of the Bradford Hill criteria.Addiction. 2016 Jul;111(7):1177-87. doi: 10.1111/add.13326. Epub 2016 Mar 30. Addiction. 2016. PMID: 27028542 Free PMC article. Review.
Cited by
-
Estimated Number of Injection-Involved Overdose Deaths in US States From 2000 to 2020: Secondary Analysis of Surveillance Data.JMIR Public Health Surveill. 2024 Apr 5;10:e49527. doi: 10.2196/49527. JMIR Public Health Surveill. 2024. PMID: 38578676 Free PMC article.
-
Organize and mobilize for implementation effectiveness to improve overdose education and naloxone distribution from syringe services programs: a randomized controlled trial.Implement Sci. 2024 Feb 28;19(1):22. doi: 10.1186/s13012-024-01354-y. Implement Sci. 2024. PMID: 38419058 Free PMC article. Clinical Trial.
-
A Qualitative Analysis of Emergency Medical Services (EMS) Personnel Experiences and Perceptions Responding to Drug Overdoses in the United States (US) During the COVID-19 Pandemic.J Health Res. 2023;37(4):270-279. doi: 10.56808/2586-940x.1045. Epub 2023 Jan 20. J Health Res. 2023. PMID: 38148880 Free PMC article.
-
Sweden's first Take-Home Naloxone program: participant characteristics, dose endpoints and predictors for overdose reversals.Subst Abuse Treat Prev Policy. 2023 Apr 22;18(1):24. doi: 10.1186/s13011-023-00533-2. Subst Abuse Treat Prev Policy. 2023. PMID: 37087485 Free PMC article.
-
Impact of an overdose reversal program in the context of a safe consumption site in Northern Mexico.Drug Alcohol Depend Rep. 2021 Dec 23;2:100021. doi: 10.1016/j.dadr.2021.100021. eCollection 2022 Mar. Drug Alcohol Depend Rep. 2021. PMID: 36845896 Free PMC article.
References
-
- Warner M, Chen LH, Makuc DM. Increase in fatal poisonings involving opioid analgesics in the United States, 1999–2006. NCHS data brief, no 22. Hyattsville, MD: National Center for Health Statistics; 2009. - PubMed
-
- Substance Abuse and Mental Health Services Administration OAS . Drug Abuse Warning Network, 2003: Area Profiles of Drug-Related Mortality. Rockville, MD: U.S. Department of Health and Human Services; 2005.
-
- Sporer KA. Acute heroin overdose. Ann Intern Med. 1999;130(7):584–590. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous